• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Bascom Palmer Eye Institute marks 60-year anniversary


The historic eye institute celebrates six decades of leadership in eye care research, education and clinical practice.

Bascom Palmer Eye Institute marks 60-year anniversary

This January, the University of Miami Miller School of Medicine’s Bascom Palmer Eye Institute, in Miami, Florida, celebrates the 60th anniversary of the opening of its first research center

The historic location first opened its doors on January 21, 1962. Then chaired by founding director Edward W.D. Norton, MD, Bascom Palmer Eye Institute became the first research center in the southeastern United States dedicated to studying and treating the eye.

Over the past 60 years, Bascom Palmer has continued to strive for excellence in ophthalmic research, education and clinical practice. In 2021, the renowned Eye Institute was ranked as the best in ophthalmology by U.S. News & World Report, which is an honor they have earned 20 times in the 32 years since the publication began running annual “Best Hospitals” rankings. The 2021 No. 1 ranking was Bascom Palmer’s 18th consecutive year receiving this designation.

“Our goal is to deliver the best possible vision care to patients throughout our diverse South Florida community and around the world,” said Eduardo C. Alfonso, MD, director, the Kathleen and Stanley J. Glaser Chair in Ophthalmology.

“I am very proud of our team’s deep commitment to patient care and passion for excellence in every aspect of our operations,” said Dr. Alfonso. “We are planning to celebrate our 60th anniversary this spring when the current COVID surge will hopefully be resolved, as we look back on our history and forward to our future.”

A storied history of ophthalmic innovation

From the very beginning, founding director Dr. Norton attracted clinicians and researchers to Bascom Palmer with the promise of innovation, compassionate care and enthusiasm for ophthalmology. Soon, the institute became known for their ophthalmic advances.

Bascom Palmer faculty celebrate 60 years

In 1970, Donald Gass, MD, discovered the fluorescein angiography procedure, which is now a world standard for diagnosis and treatment of retinal disorders.

Also in 1970, Robert Machemer, MD, piloted the first pars plana vitrectomy. Before this time, the vitreous body was avoided due to the risk of causing a retinal detachment; now, the pars plana vitrectomy is one of the most frequently performed procedures in ophthalmology. The microsurgical tools used were also developed at Bascom Palmer for this procedure specifically.

John T. Flynn, MD, a former faculty member at the Bascom Palmer Eye Institute, dedicated his career to researching retinopathy of prematurity, a condition afflicting premature infants that causes blindness. Through his research, Dr. Flynn discovered the appropriate amount of oxygen in incubators to preserve the retina and vision of premature infants, which has saved sight across the globe.

More recently, Paul F. Palmberg, MD, redefined glaucoma treatment by determining the proper target pressure in the eye, and Philip Rosenfeld, MD, developed a treatment for wet age-related macular degeneration (AMD) using Avastin (bevacizumab, Genentech), an FDA-approved drug for the treatment of colorectal cancer.

Bascom Palmer continues this tradition of excellence by leading the charge in development of new surgical procedures. They have partnered with the Institute’s bioengineering team, led by Jean-Marie Paren, PhD, and together, they have invented or improved over 350 ophthalmic instruments.

Today, the researchers are developing advanced digital applications, such as artificial intelligence and machine learning, to improve clinical care. In the laboratories, scientists are researching gene therapy, stem cells and biomechanical devices.

“Our scientists and clinicians are using large-scale clinical databases, 3D imaging technologies, and sophisticated medical therapies to benefit our patients,” Dr. Alfonso said. “Every day, our researchers collaborate with our colleagues at the Miller School of Medicine, sharing ideas and insights, and launching new laboratory and clinical research initiatives.”

Inside the clinic, Bascom Palmer ophthalmologists strive to offer the best possible care for their patients. In the face of the COVID-19 pandemic, they have deployed telehealth services and hybrid visits, which allow patients to receive virtual vision evaluations, consultations and follow-up care. Additionally, the Institute’s Global Center for Ophthalmic Education offers online instruction for vision professionals and students across the world, often utilizing video-equipped mobile robots for virtual Grand Rounds.

Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
Elizabeth Yeu, MD, highlights from a corneal case report for a patient undergoing the triple procedure
© 2024 MJH Life Sciences

All rights reserved.